Hangzhou Coco Healthcare Products Co.,Ltd.
Символ: 301009.SZ
SHZ
9.21
CNYПазарна цена днес
-72.8888
Съотношение P/E
0.0000
Коефициент PEG
2.50B
MRK Cap
- 0.00%
Доходност на DIV
Hangzhou Coco Healthcare Products Co.,Ltd. (301009-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 2932.71 | 689.5 | 884 | 439.2 | ||||||
balance-sheet.row.short-term-investments | -32.15 | -21.2 | -23.5 | 100 | ||||||
balance-sheet.row.net-receivables | 1048.46 | 274.5 | 188.2 | 247.1 | ||||||
balance-sheet.row.inventory | 567.85 | 182.4 | 153.9 | 127.8 | ||||||
balance-sheet.row.other-current-assets | 48.58 | 12.2 | 27.6 | 35.4 | ||||||
balance-sheet.row.total-current-assets | 4597.59 | 1158.5 | 1253.8 | 849.5 | ||||||
balance-sheet.row.property-plant-equipment-net | 2710.56 | 670.4 | 694.8 | 536.1 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 335.9 | 84.9 | 87 | 50.8 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 335.9 | 84.9 | 87 | 50.8 | ||||||
balance-sheet.row.long-term-investments | 105.41 | 21.5 | 23.7 | -99.8 | ||||||
balance-sheet.row.tax-assets | 36.67 | 8.2 | 2.1 | 5.9 | ||||||
balance-sheet.row.other-non-current-assets | 14.84 | 5.2 | 24.2 | 151.5 | ||||||
balance-sheet.row.total-non-current-assets | 3203.38 | 790.1 | 831.8 | 644.5 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 7800.97 | 1948.6 | 2085.6 | 1494 | ||||||
balance-sheet.row.account-payables | 1641.8 | 429.9 | 528.5 | 653.3 | ||||||
balance-sheet.row.short-term-debt | 12.46 | 1.4 | 1.5 | 99.2 | ||||||
balance-sheet.row.tax-payables | 24.29 | 6.5 | 1.4 | 23.8 | ||||||
balance-sheet.row.long-term-debt-total | 32.48 | 3.3 | 5.1 | 0 | ||||||
Deferred Revenue Non Current | 176.56 | 39.1 | 6.8 | 6.7 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | -39.05 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 2.29 | 0.8 | 0.6 | 0.2 | ||||||
balance-sheet.row.total-non-current-liabilities | 209.03 | 42.3 | 11.9 | 6.7 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 32.48 | 3.3 | 5.1 | 0 | ||||||
balance-sheet.row.total-liab | 2015.36 | 516.9 | 578.6 | 812.4 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 1087.44 | 271.9 | 271.9 | 203.9 | ||||||
balance-sheet.row.retained-earnings | 1197.28 | 284.3 | 348.8 | 314.9 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1741.95 | 73.2 | 70.8 | 94.7 | ||||||
balance-sheet.row.other-total-stockholders-equity | 1443.73 | 723.2 | 723.2 | 0 | ||||||
balance-sheet.row.total-stockholders-equity | 5470.4 | 1352.6 | 1414.7 | 613.4 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 7800.97 | 1948.6 | 2085.6 | 1494 | ||||||
balance-sheet.row.minority-interest | 315.22 | 79.2 | 92.3 | 68.1 | ||||||
balance-sheet.row.total-equity | 5785.61 | 1431.8 | 1507 | 681.5 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 7800.97 | - | - | - | ||||||
Total Investments | 24.36 | 0.3 | 0.3 | 0.3 | ||||||
balance-sheet.row.total-debt | 44.94 | 4.6 | 6.6 | 99.2 | ||||||
balance-sheet.row.net-debt | -2887.77 | -684.8 | -877.4 | -240.1 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -30.7 | -56.2 | 39.4 | 223.1 | ||||||
cash-flows.row.depreciation-and-amortization | 18.81 | 61.3 | 49.4 | 39.2 | ||||||
cash-flows.row.deferred-income-tax | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.stock-based-compensation | 0 | 6.1 | -3.8 | 3.6 | ||||||
cash-flows.row.change-in-working-capital | -71.18 | -110.7 | -53.8 | 67.3 | ||||||
cash-flows.row.account-receivables | -30.95 | -31 | 114.1 | -101.2 | ||||||
cash-flows.row.inventory | -40.23 | -40.2 | -34 | 4.5 | ||||||
cash-flows.row.account-payables | 0 | -33.5 | -137.7 | 167.6 | ||||||
cash-flows.row.other-working-capital | 0 | -6.1 | 3.8 | -3.6 | ||||||
cash-flows.row.other-non-cash-items | 220.95 | 68.5 | 15.4 | 66.2 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 137.88 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | -71.17 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.acquisitions-net | 0.22 | 0.6 | 25 | 0.1 | ||||||
cash-flows.row.purchases-of-investments | -10.56 | -65 | -95 | -150.3 | ||||||
cash-flows.row.sales-maturities-of-investments | -0.22 | 65.2 | 220.1 | 51.1 | ||||||
cash-flows.row.other-investing-activites | 34.62 | 3.4 | -24.5 | 8.3 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | -47.11 | -112.1 | -114.9 | -311.5 | ||||||
cash-flows.row.debt-repayment | 0 | 0 | -149.1 | -80.6 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | -19 | -0.9 | -23.6 | ||||||
cash-flows.row.other-financing-activites | -40.56 | -30.8 | 833.8 | 132.7 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -40.56 | -49.9 | 683.8 | 28.5 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.47 | 4.2 | -2.6 | -11.6 | ||||||
cash-flows.row.net-change-in-cash | 51.69 | -195 | 616.8 | 101.2 | ||||||
cash-flows.row.cash-at-end-of-period | 2680.47 | 639.5 | 834.4 | 217.6 | ||||||
cash-flows.row.cash-at-beginning-of-period | 2628.78 | 834.4 | 217.6 | 116.4 | ||||||
cash-flows.row.operating-cash-flow | 137.88 | -37.2 | 50.5 | 395.9 | ||||||
cash-flows.row.capital-expenditure | -71.17 | -116.4 | -240.4 | -220.7 | ||||||
cash-flows.row.free-cash-flow | 66.71 | -153.6 | -189.9 | 175.1 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1143.94 | 1186.3 | 1186.4 | 1635.1 | ||||||
income-statement-row.row.cost-of-revenue | 945.12 | 1030.9 | 965.3 | 1180.1 | ||||||
income-statement-row.row.gross-profit | 198.82 | 155.4 | 221.1 | 455 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 46.28 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 15.18 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 93.42 | - | - | - | ||||||
income-statement-row.row.other-expenses | -1.65 | -0.9 | -1.8 | 21.3 | ||||||
income-statement-row.row.operating-expenses | 173.59 | 171.3 | 176.8 | 138.8 | ||||||
income-statement-row.row.cost-and-expenses | 1118.7 | 1202.2 | 1142.1 | 1318.9 | ||||||
income-statement-row.row.interest-income | 23.48 | 23.3 | 12.6 | 4.7 | ||||||
income-statement-row.row.interest-expense | 0.53 | 0.3 | 1 | 4.3 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 93.42 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | -1.65 | -0.9 | -1.8 | -1.1 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | -1.65 | -0.9 | -1.8 | 21.3 | ||||||
income-statement-row.row.total-operating-expenses | -1.65 | -0.9 | -1.8 | -1.1 | ||||||
income-statement-row.row.interest-expense | 0.53 | 0.3 | 1 | 4.3 | ||||||
income-statement-row.row.depreciation-and-amortization | 84.04 | 61.3 | 49.4 | 39.2 | ||||||
income-statement-row.row.ebitda-caps | 46.55 | - | - | - | ||||||
income-statement-row.row.operating-income | -37.49 | -55.5 | 45.3 | 255.4 | ||||||
income-statement-row.row.income-before-tax | -39.14 | -56.4 | 43.5 | 254.3 | ||||||
income-statement-row.row.income-tax-expense | 4.18 | -0.1 | 4.1 | 31.2 | ||||||
income-statement-row.row.net-income | -30.7 | -43.1 | 39.7 | 214 |
Често задавани въпроси
Какво е Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) общи активи?
Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) общите активи са 1948631068.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 487973803.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.245.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.245.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.027.
Какъв е общият приход на предприятието?
Общият приход е -0.033.
Каква е Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -43128735.250.
Какъв е общият дълг на фирмата?
Общият дълг е 4640303.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 171278413.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 799685452.000.